NFE2L2 and pancreatic neoplasm: In summary, they observed that the activation of Nrf2 by sulforaphane inhibited high glucose-induced progression of pancreatic cancer via AMPK-dependent signaling, by the inhibition of clone formation, the migration of pancreatic cancer, and the promotion of apoptosis.